Business Description
Propanc Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US74346N1072
Description
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | -14.73 | |||||
| Debt-to-Equity | -0.29 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 80 | |||||
| 3-Year Book Growth Rate | 96.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.75 | |||||
| 9-Day RSI | 34.94 | |||||
| 14-Day RSI | 36.5 | |||||
| 6-1 Month Momentum % | -79.64 | |||||
| 12-1 Month Momentum % | -99.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2752 | |||||
| Shareholder Yield % | 491.58 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1698.23 | |||||
| ROIC % | -89.35 | |||||
| ROC (Joel Greenblatt) % | -4820.71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.53 | |||||
| EV-to-EBITDA | -0.53 | |||||
| EV-to-FCF | -1.06 | |||||
| Earnings Yield (Greenblatt) % | -188.68 | |||||
| FCF Yield % | -1813.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PPCB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Propanc Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.625 | ||
| Beta | 3.07 | ||
| Volatility % | 233.53 | ||
| 14-Day RSI | 36.5 | ||
| 14-Day ATR ($) | 0.000583 | ||
| 20-Day SMA ($) | 0.001651 | ||
| 12-1 Month Momentum % | -99.2 | ||
| 52-Week Range ($) | 0.00095 - 0.4 | ||
| Shares Outstanding (Mil) | 52.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Propanc Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Propanc Biopharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Propanc Biopharma Inc Frequently Asked Questions
What is Propanc Biopharma Inc(PPCB)'s stock price today?
The current price of PPCB is $0.00. The 52 week high of PPCB is $0.40 and 52 week low is $0.00.
When is next earnings date of Propanc Biopharma Inc(PPCB)?
The next earnings date of Propanc Biopharma Inc(PPCB) is .
Does Propanc Biopharma Inc(PPCB) pay dividends? If so, how much?
Propanc Biopharma Inc(PPCB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers